GNC HOLDINGS, INC. (NYSE:GNC) Files An 8-K Entry into a Material Definitive Agreement
Item 1.01 Entry into a Material Definitive Agreement
As previously disclosed, on February 13, 2018, GNC Holdings, Inc. (the “Company”) entered into a Securities Purchase Agreement (as amended from time to time, the “Securities Purchase Agreement”) by and between the Company and Harbin Pharmaceutical Group Holdings Co., Ltd. (the “Investor”), to which the Company agreed to issue and sell to the Investor, and the Investor agreed to purchase from the Company, 299,950 shares of a newly created series of convertible preferred stock of the Company, designated the “Series A Convertible Preferred Stock” (the “Preferred Stock”), for a purchase price of $1,000 per share, or an aggregate of approximately $300 million (the “Securities Purchase”). The Preferred Stock is convertible into shares of the common stock of the Company (the “Common Stock”) at an initial conversion price of $5.35 per share, subject to customary anti-dilution adjustments. to the terms of the Securities Purchase Agreement, the Investor assigned its interest in the Securities Purchase Agreement to Harbin Pharmaceutical Group Co., Ltd., a company incorporated in the People’s Republic of China (“Hayao”).
Also as previously disclosed, on November 7, 2018, the Company and Hayao entered into an Amendment to the Securities Purchase Agreement, to which the Company and Hayao agreed, among other things, to complete the Securities Purchase as follows: (i) 100,000 shares of Preferred Stock to be issued on or about November 9, 2018 for a total purchase price of $100,000,000 (the “Initial Issuance”), (ii) 50,000 shares of Preferred Stock to be issued on or about December 28, 2018 for a total purchase price of $50,000,000 (the “Second Issuance”) and (iii) 149,950 shares of Preferred Stock to be issued on or about February 13, 2019 for a total purchase price of $149,950,000 (the “Third Issuance”). The Initial Issuance was completed on November 8, 2018 and the Second Issuance was completed on January 2, 2019.
Closing of Third Issuance
On February 13, 2019, the Company and Hayao consummated the Third Issuance to the terms of the Securities Purchase Agreement. In connection with the Third Issuance and to set forth the rights and obligations of Hayao upon the Third Issuance, the Company and Hayao entered into an Amended and Restated Stockholders Agreement, dated as of February 13, 2019 (the “Stockholders Agreement”). The Stockholders Agreement is substantially similar to the Form of Stockholders Agreement described in the Current Report on Form 8-K filed with the Securities and Exchange Commission (the “SEC”) on February 13, 2018 and attached as Exhibit D to the Securities Purchase Agreement filed as Exhibit 10.1 thereto. Such description is not purported to be complete and is qualified in its entirety by reference to the full text of the Stockholders Agreement, which is attached hereto as Exhibit 10.1 and is incorporated by reference into this Item 1.01.
China Joint Venture
As previously disclosed, on November 7, 2018, the Company entered into a Master Reorganization and Subscription Agreement (as amended, the “JV Framework Agreement”) by and between the Company, GNC Hong Kong Limited, a company established under the laws of Hong Kong (the “HK Company”), GNC (Shanghai) Trading Co., Ltd., a company incorporated in the People’s Republic of China (the “PRC”) (the “WFOE”), GNC China Holdco, LLC, a Delaware corporation (“GNC China”), Hayao, and Harbin Pharmaceutical Hong Kong II Limited, a company established under the laws of Hong Kong (“Hayao HK” and together with the other parties to the JV Framework Agreement, the “JV Parties”). to the JV Framework Agreement, among other things, (i) Hayao HK will acquire shares representing 65% of the HK Company’s issued share capital and the HK Company will become a joint venture between Hayao HK and GNC China (the “HK JV”); (ii) the WFOE will transfer its assets and liabilities primarily related to the PRC Business (as defined in the JV Framework Agreement) to a newly formed entity in the PRC (the “PRC JV”); (iii) Hayao will acquire shares representing sixty-five percent (65%) of the issued and outstanding capital of the PRC JV; and (iv) Hayao will invest $20.0 million in the PRC JV (clauses (i)-(iv) collectively, together with the other transactions contemplated by the JV Framework Agreement, the “JV Transactions”).
On February 13, 2019, the Company and the other JV Parties entered into an Amendment to the Master Reorganization and Subscription Agreement (the “Amendment”), to which the JV Parties agreed to close the HK JV concurrently with the Amendment and to close the PRC JV on a deferred basis upon receipt of requisite PRC regulatory and legal approvals. The foregoing description of the Amendment is only a summary, does not purport to be complete and is qualified in its entirety by reference to the full text of the Amendment, a copy of which is attached hereto as Exhibit 10.2 and is incorporated by reference into this Item 1.01.
Closing of the HK JV Formation
On February 13, 2019, the JV Parties consummated the HK JV and the JV Transactions related thereto (the “HK JV Closing”) to the terms of the JV Framework Agreement. In connection with the HK JV Closing and in accordance with the JV Framework Agreement, (i) the Company, Hayao, GNC China, Hayao HK and the HK Company entered into a Shareholders Agreement, dated as of February 13, 2019 (the “HK Shareholders Agreement”), (ii) the HK Company, General Nutrition
Corporation and GNC Intellectual Property Holdings, LLC (“GNC IPCo”) entered into an Intellectual Property License Agreement, dated as of February 13, 2019 (the “IP License Agreement”), (iii) the HK Company and General Nutrition Corporation entered into a Product Supply Agreement, dated as of February 13, 2019 (the “Product Supply Agreement”), and (iv) General Nutrition Corporation and Hayao entered into a Services Letter Agreement, dated as of February 13, 2019 (the “Services Letter Agreement”, and together with the Product Supply Agreement, the IP License Agreement and the HK Shareholders Agreement, the “HK JV Agreements”).
The terms and conditions of the HK JV Agreements are described in our Current Report on Form 8-K as filed with the SEC on November 7, 2018. Such description is not purported to be complete and is qualified in its entirety by reference to the full text of the Form of HK Shareholders Agreement, the Form of IP License Agreement, the Form of Product Supply Agreement, and the Form of Services Letter Agreement (the “Form JV Agreements”), which were filed on November 13, 2018 in our Current Report on Form 8-K as Exhibit B (Form of HK Shareholders Agreement), Exhibit D (Form of IP License Agreement), Exhibit E (Form of Product Supply Agreement) and Exhibit F (Form of Services Letter Agreement) to the Master Reorganization and Subscription Agreement, attached as Exhibit 10.1 to such Current Report and are incorporated by reference into this Item 1.01. The HK JV Agreements are substantially similar to the Form JV Agreements, modified in each case solely to reflect that closing of the PRC JV will occur after the closing of the HK JV, as further described in the Amendment.
Item 7.01 Regulation FD Disclosure
On February 13, 2019, the Company issued a press release announcing that the Company and Hayao consummated the Third Issuance and the closing of the HK JV. A copy of the Company’s press release containing such announcement is attached as Exhibit 99.1 to this Current Report on Form 8-K.
The foregoing information (including Exhibit 99.1) is furnished to Item 7.01 of Form 8-K and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section, nor shall it be deemed to be incorporated by reference in any filing under the Securities Act, except as may be expressly set forth by specific reference in such filing.
Item 9.01.Financial Statements and Exhibits.
(d)Exhibits:
GNC HOLDINGS, INC. Exhibit
EX-10.1 2 omega-hkshareholdersagreem.htm EXHIBIT 10.1 Exhibit Execution VersionSHAREHOLDERS AGREEMENT (GNC-Harbin HK Ltd.) related toGNC HONG KONG LIMITEDBy and amongGNC HOLDINGS,…
To view the full exhibit click here
About GNC HOLDINGS, INC. (NYSE:GNC)
GNC Holdings, Inc. is a specialty retailer of health, wellness and performance products, including vitamins, minerals and herbal supplement products (VMHS), sports nutrition products and diet products. The Company operates in three segments: Retail, Franchising and Manufacturing/Wholesale. The Retail segment includes sales of products to customers at its company-owned stores in the United States, Canada, Puerto Rico and Ireland and through its Websites, GNC.com and LuckyVitamin.com. Its Franchise segment consists of its domestic and international franchise operations. Its Manufacturing/Wholesale segment consists of its manufacturing operations in South Carolina and its wholesale sales business. The Company’s brands include Mega Men, Ultra Mega, Total Lean, Pro Performance and Pro Performance AMP, Beyond Raw, GNC Puredge, GNC GenetixHD and Herbal Plus. The Company offers products through GNC.com, LuckyVitamin.com and www.drugstore.com.
